Prospectus of the First 2016 Medical Robotics Seminar Series Organized by Global Doctors Organization and Beijing Huabo Ruite Technology Co., Ltd.

Global Doctors Organization and Beijing Huaboruite Technology Co., Ltd. jointly hosted the first 2016 seminar series on medical robots (January 15). The event brought together 65 participants, including domestic and international investment institutions, robotics R&D organizations, and government-led industrial incubation funds. This initiative officially launched a new chapter in collaborative innovation across investment, research and development, and market synergy, with medical robots as the core theme.



China is the world’s largest market for intelligent robots in the healthcare and broader health sectors. Although it currently lacks core technologies and mature products, it has no shortage of capital or opportunities. The industrialization and commercial translation of medical robots in China are poised for takeoff, offering substantial room for industrial growth and attractive investment returns.

I. Establishing a Platform for Communication and Collaboration

According to preliminary statistics, the institutions participating in this event comprised 62% investment or fund firms and 38% medical technology and internet technology companies. Among the attendees, 59% were senior management and decision-makers (CEOs, directors, managing partners, and general managers). There were eight national-level government fund institutions and venture incubation funds, as well as 20 investment firms managing or holding investment assets exceeding RMB 5 billion. Based on publicly available information from these investment firms, the total assets (invested and managed capital) of the participating investment institutions reached RMB 150 billion. It truly feels like “even a pig can fly if it’s standing at the eye of the storm!”

The significant attention from investment institutions toward the medical robotics sector, along with their joint exploration of investment opportunities, will undoubtedly lay a sustainable foundation for the industrialization of medical robotics in China.

II. Problem-Solving Oriented

The purpose of this event is to establish a network for exchange and collaboration between the investment community and the industry, thereby reducing investment risks while maximizing and accelerating the layout of China’s industrialization roadmap for medical robots. From the perspective of demand in the healthcare and broader health sectors, there is a sharp increase in high-end demands for disease diagnosis and treatment, as well as in elderly care, rehabilitation, and nursing services. Meanwhile, the supply of professional medical personnel and health management experts remains insufficient, compounded by lengthy education and training cycles. Consequently, medical robots can effectively address the balance between supply and demand in “productivity” and deliver specialized, precise services.

From the perspective of mature product and technology supply, China’s marketed medical robot products and core technology R&D are still in their nascent stages. However, due to the relative overcapacity in domestic electronic products and high-tech manufacturing, optimal opportunities have emerged through the horizontal integration of technology, industry, capital, and markets, serving as a catalyst for the development of the medical robotics industry.

The choice facing investment firms and R&D teams is whether the industrialization of medical robots should be driven by vertical application markets or follow the traditional path from technological research and development to commercialization—a core issue testing all stakeholders in this field.

III. Investment Philosophy and Expected Returns

Investing in the field of medical robots, whether by emulating successful overseas cases or following the commercial return patterns of investment and incubation funds, is a worthwhile endeavor. Some institutions involved in this exchange still focus on “mature products and core technologies,” while lacking a deep understanding of vertical application markets and precise distribution channels—specifically, how to build intelligent robot service platforms and manage big data. While mastering core technologies offers short-term business opportunities, the risks associated with investing in mature technologies and products are actually higher than those related to controlling application markets and precise channels, particularly in the early stages of industrialization for medical robots. This is due to the networked nature of global innovation collaboration (driven by internet and cloud technologies), the need for continuous market feedback to perfect products and technologies, and the rapid pace of iteration. Ultimately, the true “path to success” and high returns lie in capturing vertical markets and establishing precise service platforms.

Medical robots are essentially transmission channels through which intelligent terminals deliver “functional capabilities and meaningful information.” For example, the “Xiao La Jiao” smart home-service robot, invested in by SoftBank, Alibaba, and Foxconn, targets the vertical market of domestic housekeeping services. Its core commercial barriers lie in its reliance on application-based products (fee-based services) and its data management platform (for big data mining and secondary development applications). Similarly, the true significance of the “Wei Hu” telemedicine robot promoted here lies in expanding its clinical application scenarios and pragmatically addressing the “transmission” of high-quality medical service resources, as well as home-based management of chronic diseases, rather than solving the challenges of disease diagnosis and treatment.

Medical Robotics Symposium and Exchange Event

The organization and invitation process for this thematic event followed the “Internet + WeChat” model. The organizers extend their gratitude to the heads of investment and R&D institutions, as well as experts, for demonstrating such a pragmatic spirit and enthusiasm by being readily available and actively engaging in discussions upon request. Special thanks are due to the experts from the Wu Jieping Medical Foundation, Peking University International Hospital, and Pudong Hospital Affiliated to Fudan University in Shanghai for sharing their valuable experiences and consensus.

This year, the organizers plan to focus on “Medical Robots” as the theme, gradually expanding from collaborations with domestic R&D institutions, investment firms, and government-led startup incubation funds into a global international forum on medical robotics and a platform for collaborative innovation and R&D.

During the planned exchange activities, we will invite top-tier international experts in the forefront of medical robotics—covering areas such as robotic systems for simulated minimally invasive surgery, wearable exoskeletons, and miniature soft robots—as well as investment specialists with proven track records in successful medical robotics ventures. They will share their expertise and highlight key considerations across various aspects of the field. Ultimately, we aim to establish the “Medical Robotics” symposium as an incubation platform for China’s medical robotics industry and a premier training ground (“Whampoa Military Academy”) for innovative talents with a global perspective.

Our mission is to “face challenges, seize opportunities, and foster collaborative development.” With this in mind, we sincerely invite domestic and international investment institutions, experts in the medical robotics industry, and like-minded partners to join us in realizing our vision: establishing a premier platform for China’s medical robotics industry and technology transfer.

Welcome to follow our WeChat official account.

Huaboruite (TheChinaBright)

Functional Overview: Technical consulting and training for intelligent medical robots, product sales, and agency services. Offerings include telemedicine robots, minimally invasive surgery simulation systems, rehabilitation and nursing care robots, smart prosthetics/AI-enabled organs, and specialized miniature medical robots.